Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Asthma and COPD Drugs Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Asthma and COPD Drugs Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 COPD
      • 1.3.3 Asthma
    • 1.4 Market Segment by Application
      • 1.4.1 Global Asthma and COPD Drugs Market Share by Application (2019-2025)
      • 1.4.2 Combination Products
      • 1.4.3 Leukotriene Antagonists (LTA)
      • 1.4.4 Inhaled Corticosteroids (ICS)
      • 1.4.5 Anticholinergics
      • 1.4.6 Short Acting Beta Agonists(SABA)
      • 1.4.7 Long Acting Beta Agonists (LABA)
      • 1.4.8 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Asthma and COPD Drugs Market Size
      • 2.1.1 Global Asthma and COPD Drugs Revenue 2014-2025
      • 2.1.2 Global Asthma and COPD Drugs Sales 2014-2025
    • 2.2 Asthma and COPD Drugs Growth Rate by Regions
      • 2.2.1 Global Asthma and COPD Drugs Sales by Regions 2014-2019
      • 2.2.2 Global Asthma and COPD Drugs Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Asthma and COPD Drugs Sales by Manufacturers
      • 3.1.1 Asthma and COPD Drugs Sales by Manufacturers 2014-2019
      • 3.1.2 Asthma and COPD Drugs Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Asthma and COPD Drugs Revenue by Manufacturers (2014-2019)
      • 3.2.2 Asthma and COPD Drugs Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Asthma and COPD Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.3 Asthma and COPD Drugs Price by Manufacturers
    • 3.4 Key Manufacturers Asthma and COPD Drugs Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Asthma and COPD Drugs Market
    • 3.6 Key Manufacturers Asthma and COPD Drugs Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 COPD Sales and Revenue (2014-2019)
      • 4.1.2 Asthma Sales and Revenue (2014-2019)
    • 4.2 Global Asthma and COPD Drugs Sales Market Share by Type
    • 4.3 Global Asthma and COPD Drugs Revenue Market Share by Type
    • 4.4 Asthma and COPD Drugs Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Asthma and COPD Drugs Sales by Application

    6 United States

    • 6.1 United States Asthma and COPD Drugs Breakdown Data by Company
    • 6.2 United States Asthma and COPD Drugs Breakdown Data by Type
    • 6.3 United States Asthma and COPD Drugs Breakdown Data by Application

    7 European Union

    • 7.1 European Union Asthma and COPD Drugs Breakdown Data by Company
    • 7.2 European Union Asthma and COPD Drugs Breakdown Data by Type
    • 7.3 European Union Asthma and COPD Drugs Breakdown Data by Application

    8 China

    • 8.1 China Asthma and COPD Drugs Breakdown Data by Company
    • 8.2 China Asthma and COPD Drugs Breakdown Data by Type
    • 8.3 China Asthma and COPD Drugs Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Asthma and COPD Drugs Breakdown Data by Company
    • 9.2 Rest of World Asthma and COPD Drugs Breakdown Data by Type
    • 9.3 Rest of World Asthma and COPD Drugs Breakdown Data by Application
    • 9.4 Rest of World Asthma and COPD Drugs Breakdown Data by Countries
      • 9.4.1 Rest of World Asthma and COPD Drugs Sales by Countries
      • 9.4.2 Rest of World Asthma and COPD Drugs Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 GlaxoSmithKline
      • 10.1.1 GlaxoSmithKline Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Asthma and COPD Drugs
      • 10.1.4 Asthma and COPD Drugs Product Introduction
      • 10.1.5 GlaxoSmithKline Recent Development
    • 10.2 Novartis
      • 10.2.1 Novartis Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Asthma and COPD Drugs
      • 10.2.4 Asthma and COPD Drugs Product Introduction
      • 10.2.5 Novartis Recent Development
    • 10.3 Merck
      • 10.3.1 Merck Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Asthma and COPD Drugs
      • 10.3.4 Asthma and COPD Drugs Product Introduction
      • 10.3.5 Merck Recent Development
    • 10.4 Abbott Laboratories
      • 10.4.1 Abbott Laboratories Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Asthma and COPD Drugs
      • 10.4.4 Asthma and COPD Drugs Product Introduction
      • 10.4.5 Abbott Laboratories Recent Development
    • 10.5 Boehringer Ingelheim
      • 10.5.1 Boehringer Ingelheim Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Asthma and COPD Drugs
      • 10.5.4 Asthma and COPD Drugs Product Introduction
      • 10.5.5 Boehringer Ingelheim Recent Development
    • 10.6 AstraZeneca
      • 10.6.1 AstraZeneca Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Asthma and COPD Drugs
      • 10.6.4 Asthma and COPD Drugs Product Introduction
      • 10.6.5 AstraZeneca Recent Development
    • 10.7 Roche Holding AG
      • 10.7.1 Roche Holding AG Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Asthma and COPD Drugs
      • 10.7.4 Asthma and COPD Drugs Product Introduction
      • 10.7.5 Roche Holding AG Recent Development
    • 10.8 Teva Pharmaceutical Industries
      • 10.8.1 Teva Pharmaceutical Industries Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Asthma and COPD Drugs
      • 10.8.4 Asthma and COPD Drugs Product Introduction
      • 10.8.5 Teva Pharmaceutical Industries Recent Development
    • 10.9 Vectura Group
      • 10.9.1 Vectura Group Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Asthma and COPD Drugs
      • 10.9.4 Asthma and COPD Drugs Product Introduction
      • 10.9.5 Vectura Group Recent Development
    • 10.10 Pfizer
      • 10.10.1 Pfizer Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Asthma and COPD Drugs
      • 10.10.4 Asthma and COPD Drugs Product Introduction
      • 10.10.5 Pfizer Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Asthma and COPD Drugs Sales Channels
      • 11.2.2 Asthma and COPD Drugs Distributors
    • 11.3 Asthma and COPD Drugs Customers

    12 Market Forecast

    • 12.1 Global Asthma and COPD Drugs Sales and Revenue Forecast 2019-2025
    • 12.2 Global Asthma and COPD Drugs Sales Forecast by Type
    • 12.3 Global Asthma and COPD Drugs Sales Forecast by Application
    • 12.4 Asthma and COPD Drugs Forecast by Regions
      • 12.4.1 Global Asthma and COPD Drugs Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Asthma and COPD Drugs Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Asthma is a chronic respiratory disease blocking the airways of lung because of inflammation, mucus production, tighten of muscles. Chronic Obstructive Pulmonary Disease(COPD) is caused by obstruction in the airways causing difficulty in breathing, with the primary cause as tobacco smoking.
      The Global Asthma and COPD Drugs market is segmented based on disease, medication class and geography. Based on disease, the market is categorized into asthma and COPD.
      In 2019, the market size of Asthma and COPD Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Asthma and COPD Drugs.

      This report studies the global market size of Asthma and COPD Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Asthma and COPD Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      GlaxoSmithKline
      Novartis
      Merck
      Abbott Laboratories
      Boehringer Ingelheim
      AstraZeneca
      Roche Holding AG
      Teva Pharmaceutical Industries
      Vectura Group
      Pfizer

      Market Segment by Product Type
      COPD
      Asthma

      Market Segment by Application
      Combination Products
      Leukotriene Antagonists (LTA)
      Inhaled Corticosteroids (ICS)
      Anticholinergics
      Short Acting Beta Agonists(SABA)
      Long Acting Beta Agonists (LABA)
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Asthma and COPD Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Asthma and COPD Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Asthma and COPD Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now